Specialty Business Services
Compare Stocks
5 / 10Stock Comparison
THH vs GAMB vs DKNG vs GENI vs SRAD
Revenue, margins, valuation, and 5-year total return — side by side.
Gambling, Resorts & Casinos
Gambling, Resorts & Casinos
Internet Content & Information
Software - Application
THH vs GAMB vs DKNG vs GENI vs SRAD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Business Services | Gambling, Resorts & Casinos | Gambling, Resorts & Casinos | Internet Content & Information | Software - Application |
| Market Cap | $16M | $149M | $12.20B | $1.15B | $3.75B |
| Revenue (TTM) | $24M | $155M | $6.29B | $713M | $1.33B |
| Net Income (TTM) | $103K | $2M | $59M | $-159M | $70M |
| Gross Margin | 18.9% | 93.2% | 41.8% | 22.6% | 38.2% |
| Operating Margin | 2.4% | 2.6% | 0.6% | -18.3% | 9.3% |
| Forward P/E | 9999.0x | 8.3x | 100.7x | 163.0x | 31.4x |
| Total Debt | $13.98B | $28M | $1.93B | $30M | $63M |
| Cash & Equiv. | $93M | $14M | $1.60B | $281M | $365M |
THH vs GAMB vs DKNG vs GENI vs SRAD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Gambling.com Group … (GAMB) | 100 | 46.5 | -53.5% |
| DraftKings Inc. (DKNG) | 100 | 51.1 | -48.9% |
| Genius Sports Limit… (GENI) | 100 | 23.8 | -76.2% |
| Sportradar Group AG (SRAD) | 100 | 55.9 | -44.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: THH vs GAMB vs DKNG vs GENI vs SRAD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
THH is the #2 pick in this set and the best alternative if growth is your priority.
- 6.1% revenue growth vs SRAD's 12.0%
GAMB ranks third and is worth considering specifically for value.
- Lower P/E (8.3x vs 163.0x)
DKNG is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 27.0%, EPS growth 99.2%, 3Y rev CAGR 39.3%
- 151.1% 10Y total return vs GAMB's -46.9%
- -35.1% vs THH's -98.7%
Among these 5 stocks, GENI doesn't own a clear edge in any measured category.
SRAD carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- beta 0.63
- Lower volatility, beta 0.63, Low D/E 6.4%, current ratio 1.17x
- Beta 0.63, current ratio 1.17x
- 5.2% margin vs GENI's -22.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.1% revenue growth vs SRAD's 12.0% | |
| Value | Lower P/E (8.3x vs 163.0x) | |
| Quality / Margins | 5.2% margin vs GENI's -22.3% | |
| Stability / Safety | Beta 0.63 vs THH's 2.24, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | -35.1% vs THH's -98.7% | |
| Efficiency (ROA) | 2.7% ROA vs GENI's -15.4%, ROIC 12.9% vs -16.6% |
THH vs GAMB vs DKNG vs GENI vs SRAD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
THH vs GAMB vs DKNG vs GENI vs SRAD — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GAMB leads in 2 of 6 categories
SRAD leads 1 • DKNG leads 1 • THH leads 0 • GENI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SRAD leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DKNG is the larger business by revenue, generating $6.3B annually — 264.0x THH's $24M. SRAD is the more profitable business, keeping 5.2% of every revenue dollar as net income compared to GENI's -22.3%. On growth, THH holds the edge at +36.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $24M | $155M | $6.3B | $713M | $1.3B |
| EBITDAEarnings before interest/tax | $1M | $20M | $313M | -$54M | $308M |
| Net IncomeAfter-tax profit | $103,366 | $2M | $59M | -$159M | $70M |
| Free Cash FlowCash after capex | -$2M | $39M | $679M | $16M | $363M |
| Gross MarginGross profit ÷ Revenue | +18.9% | +93.2% | +41.8% | +22.6% | +38.2% |
| Operating MarginEBIT ÷ Revenue | +2.4% | +2.6% | +0.6% | -18.3% | +9.3% |
| Net MarginNet income ÷ Revenue | +0.4% | +1.2% | +0.9% | -22.3% | +5.2% |
| FCF MarginFCF ÷ Revenue | -7.1% | +25.3% | +10.8% | +2.2% | +27.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +36.2% | +21.4% | +16.8% | +30.5% | +13.2% |
| EPS Growth (YoY)Latest quarter vs prior year | — | -145.8% | +157.7% | -6.0% | -128.5% |
Valuation Metrics
GAMB leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 5.1x trailing earnings, GAMB trades at a 100% valuation discount to THH's 9999.0x P/E. On an enterprise value basis, GAMB's 3.9x EV/EBITDA is more attractive than DKNG's 48.3x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $16M | $149M | $12.2B | $1.1B | $3.7B |
| Enterprise ValueMkt cap + debt − cash | $104M | $164M | $12.5B | $896M | $3.4B |
| Trailing P/EPrice ÷ TTM EPS | 9999.00x | 5.06x | -3038.27x | -10.11x | 35.90x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 8.30x | 100.70x | 163.00x | 31.45x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 0.63x |
| EV / EBITDAEnterprise value multiple | 18.65x | 3.95x | 48.25x | — | 16.34x |
| Price / SalesMarket cap ÷ Revenue | 0.10x | 1.18x | 2.02x | 1.71x | 2.57x |
| Price / BookPrice ÷ Book value/share | 465.57x | 1.25x | 19.33x | 1.56x | 3.52x |
| Price / FCFMarket cap ÷ FCF | — | 39.20x | 18.84x | 17.76x | 8.33x |
Profitability & Efficiency
GAMB leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
DKNG delivers a 7.9% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-22 for GENI. GENI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to DKNG's 3.06x. On the Piotroski fundamental quality scale (0–9), GAMB scores 7/9 vs GENI's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +0.0% | +1.4% | +7.9% | -22.2% | +7.3% |
| ROA (TTM)Return on assets | +0.0% | +0.7% | +1.3% | -15.4% | +2.7% |
| ROICReturn on invested capital | +2.7% | +23.0% | -0.9% | -16.6% | +12.9% |
| ROCEReturn on capital employed | +4.1% | +26.3% | -0.6% | -15.3% | +5.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 | 7 | 3 | 4 |
| Debt / EquityFinancial leverage | 2.58x | 0.23x | 3.06x | 0.04x | 0.06x |
| Net DebtTotal debt minus cash | $13.9B | $14M | $330M | -$250M | -$302M |
| Cash & Equiv.Liquid assets | $93M | $14M | $1.6B | $281M | $365M |
| Total DebtShort + long-term debt | $14.0B | $28M | $1.9B | $30M | $63M |
| Interest CoverageEBIT ÷ Interest expense | 2698.44x | 1.79x | 4.48x | -75.96x | 2.02x |
Total Returns (Dividends Reinvested)
DKNG leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DKNG five years ago would be worth $5,844 today (with dividends reinvested), compared to $131 for THH. Over the past 12 months, DKNG leads with a -35.1% total return vs THH's -98.7%. The 3-year compound annual growth rate (CAGR) favors SRAD at 3.0% vs THH's -76.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -98.4% | -19.7% | -31.0% | -58.7% | -45.7% |
| 1-Year ReturnPast 12 months | -98.7% | -70.1% | -35.1% | -56.9% | -45.3% |
| 3-Year ReturnCumulative with dividends | -98.7% | -57.5% | +4.6% | -3.9% | +9.4% |
| 5-Year ReturnCumulative with dividends | -98.7% | -46.9% | -41.6% | -74.4% | -49.5% |
| 10-Year ReturnCumulative with dividends | -98.7% | -46.9% | +151.1% | -55.5% | -49.5% |
| CAGR (3Y)Annualised 3-year return | -76.5% | -24.8% | +1.5% | -1.3% | +3.0% |
Risk & Volatility
Evenly matched — DKNG and SRAD each lead in 1 of 2 comparable metrics.
Risk & Volatility
SRAD is the less volatile stock with a 0.63 beta — it tends to amplify market swings less than THH's 2.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DKNG currently trades 50.5% from its 52-week high vs THH's 0.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.24x | 1.38x | 1.06x | 1.39x | 0.63x |
| 52-Week HighHighest price in past year | $55.05 | $14.95 | $48.78 | $13.73 | $32.22 |
| 52-Week LowLowest price in past year | $0.31 | $3.51 | $20.46 | $3.83 | $11.66 |
| % of 52W HighCurrent price vs 52-week peak | +0.6% | +28.4% | +50.5% | +32.4% | +39.3% |
| RSI (14)Momentum oscillator 0–100 | 37.6 | 64.2 | 56.0 | 46.4 | 36.5 |
| Avg Volume (50D)Average daily shares traded | 467K | 742K | 13.1M | 5.7M | 3.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: GAMB as "Buy", DKNG as "Buy", GENI as "Buy", SRAD as "Buy". Consensus price targets imply 151.0% upside for GENI (target: $11) vs 48.9% for DKNG (target: $37).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $7.00 | $36.64 | $11.17 | $20.85 |
| # AnalystsCovering analysts | — | 8 | 48 | 19 | 20 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | 1 | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +18.1% | +6.8% | 0.0% | +3.2% |
GAMB leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). SRAD leads in 1 (Income & Cash Flow). 1 tied.
THH vs GAMB vs DKNG vs GENI vs SRAD: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is THH or GAMB or DKNG or GENI or SRAD a better buy right now?
For growth investors, TryHard Holdings Limited (THH) is the stronger pick with 609.
9% revenue growth year-over-year, versus 12. 0% for Sportradar Group AG (SRAD). Gambling. com Group Limited (GAMB) offers the better valuation at 5. 1x trailing P/E (8. 3x forward), making it the more compelling value choice. Analysts rate Gambling. com Group Limited (GAMB) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — THH or GAMB or DKNG or GENI or SRAD?
On trailing P/E, Gambling.
com Group Limited (GAMB) is the cheapest at 5. 1x versus TryHard Holdings Limited at 9999. 0x. On forward P/E, Gambling. com Group Limited is actually cheaper at 8. 3x.
03Which is the better long-term investment — THH or GAMB or DKNG or GENI or SRAD?
Over the past 5 years, DraftKings Inc.
(DKNG) delivered a total return of -41. 6%, compared to -98. 7% for TryHard Holdings Limited (THH). Over 10 years, the gap is even starker: DKNG returned +151. 1% versus THH's -98. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — THH or GAMB or DKNG or GENI or SRAD?
By beta (market sensitivity over 5 years), Sportradar Group AG (SRAD) is the lower-risk stock at 0.
63β versus TryHard Holdings Limited's 2. 24β — meaning THH is approximately 253% more volatile than SRAD relative to the S&P 500. On balance sheet safety, Genius Sports Limited (GENI) carries a lower debt/equity ratio of 4% versus 3% for DraftKings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — THH or GAMB or DKNG or GENI or SRAD?
By revenue growth (latest reported year), TryHard Holdings Limited (THH) is pulling ahead at 609.
9% versus 12. 0% for Sportradar Group AG (SRAD). On earnings-per-share growth, the picture is similar: Sportradar Group AG grew EPS 200. 0% year-over-year, compared to -99. 9% for TryHard Holdings Limited. Over a 3-year CAGR, GAMB leads at 44. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — THH or GAMB or DKNG or GENI or SRAD?
Gambling.
com Group Limited (GAMB) is the more profitable company, earning 24. 1% net margin versus -16. 7% for Genius Sports Limited — meaning it keeps 24. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GAMB leads at 28. 1% versus -15. 6% for GENI. At the gross margin level — before operating expenses — GAMB leads at 94. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is THH or GAMB or DKNG or GENI or SRAD more undervalued right now?
On forward earnings alone, Gambling.
com Group Limited (GAMB) trades at 8. 3x forward P/E versus 163. 0x for Genius Sports Limited — 154. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GENI: 151. 0% to $11. 17.
08Which pays a better dividend — THH or GAMB or DKNG or GENI or SRAD?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is THH or GAMB or DKNG or GENI or SRAD better for a retirement portfolio?
For long-horizon retirement investors, Sportradar Group AG (SRAD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
63)). TryHard Holdings Limited (THH) carries a higher beta of 2. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SRAD: -49. 5%, THH: -98. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between THH and GAMB and DKNG and GENI and SRAD?
These companies operate in different sectors (THH (Industrials) and GAMB (Consumer Cyclical) and DKNG (Consumer Cyclical) and GENI (Communication Services) and SRAD (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: THH is a small-cap high-growth stock; GAMB is a small-cap high-growth stock; DKNG is a mid-cap high-growth stock; GENI is a small-cap high-growth stock; SRAD is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 15%
- Gross Margin > 13%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.